These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 23046321

  • 21. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
    Micari A, Vadalà G, Castriota F, Liso A, Grattoni C, Russo P, Marchese A, Pantaleo P, Roscitano G, Cesana BM, Cremonesi A.
    JACC Cardiovasc Interv; 2016 May 09; 9(9):950-6. PubMed ID: 27151609
    [Abstract] [Full Text] [Related]

  • 22. Update on PADI trial: percutaneous transluminal angioplasty and drug-eluting stents for infrapopliteal lesions in critical limb ischemia.
    Martens JM, Knippenberg B, Vos JA, de Vries JP, Hansen BE, van Overhagen H, PADI Trial Group.
    J Vasc Surg; 2009 Sep 09; 50(3):687-9. PubMed ID: 19700099
    [Abstract] [Full Text] [Related]

  • 23. Commentary: aligning incentives of payer, facility, and provider: the lynchpin of providing more cost-effective care.
    Sternbergh WC.
    J Endovasc Ther; 2013 Dec 09; 20(6):826-7. PubMed ID: 24325700
    [No Abstract] [Full Text] [Related]

  • 24. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry.
    Micari A, Cioppa A, Vadalà G, Castriota F, Liso A, Marchese A, Grattoni C, Pantaleo P, Cremonesi A, Rubino P, Biamino G.
    JACC Cardiovasc Interv; 2013 Mar 09; 6(3):282-9. PubMed ID: 23517840
    [Abstract] [Full Text] [Related]

  • 25. Vasculitis resulting from a superficial femoral artery angioplasty with a paclitaxel-eluting balloon.
    Thomas SD, McDonald RR, Varcoe RL.
    J Vasc Surg; 2014 Feb 09; 59(2):520-3. PubMed ID: 23642919
    [Abstract] [Full Text] [Related]

  • 26. German Center Subanalysis of the LEVANT 2 Global Randomized Study of the Lutonix Drug-Coated Balloon in the Treatment of Femoropopliteal Occlusive Disease.
    Scheinert D, Schmidt A, Zeller T, Müller-Hülsbeck S, Sixt S, Schröder H, Weiss N, Ketelsen D, Ricke J, Steiner S, Rosenfield K.
    J Endovasc Ther; 2016 Jun 09; 23(3):409-16. PubMed ID: 27117972
    [Abstract] [Full Text] [Related]

  • 27. The effectiveness of the paclitaxel-coated Luminor® balloon catheter versus an uncoated balloon catheter in superficial femoral and popliteal arteries in preventing vessel restenosis or reocclusion: study protocol for a randomized controlled trial.
    Teichgräber U, Aschenbach R, Scheinert D, Zeller T, Brechtel K, Thieme M, Blessing E, Treitl M, Lichtenberg M, von Flotow P, Vogel B, Werk M, Riambau V, Wienke A, Lehmann T, Sixt S.
    Trials; 2016 Oct 28; 17(1):528. PubMed ID: 27793175
    [Abstract] [Full Text] [Related]

  • 28. A new paclitaxel-eluting balloon for angioplasty of femoropopliteal obstructions: acute and midterm results.
    Micari A, Cioppa A, Vadalà G, Stabile E, Castriota F, Pantaleo P, Grattoni C, Cremonesi A, Marchese A, Rubino P, Biamino G.
    EuroIntervention; 2011 May 28; 7 Suppl K():K77-82. PubMed ID: 22027734
    [Abstract] [Full Text] [Related]

  • 29. Paclitaxel-Eluting Balloon vs Standard Angioplasty to Reduce Restenosis in Diabetic Patients With In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Arteries: Three-Year Results of the DEBATE-ISR Study.
    Grotti S, Liistro F, Angioli P, Ducci K, Falsini G, Porto I, Ricci L, Ventoruzzo G, Turini F, Bellandi G, Bolognese L.
    J Endovasc Ther; 2016 Feb 28; 23(1):52-7. PubMed ID: 26511896
    [Abstract] [Full Text] [Related]

  • 30. Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease.
    Mehrotra S, Paramasivam G, Mishra S.
    Curr Cardiol Rep; 2017 Feb 28; 19(2):10. PubMed ID: 28185166
    [Abstract] [Full Text] [Related]

  • 31. Endovascular techniques in limb salvage: cutting, cryo, brachy, and drug-eluting balloons.
    Davies MG, Anaya-Ayala JE.
    Methodist Debakey Cardiovasc J; 2013 Apr 28; 9(2):69-72. PubMed ID: 23805337
    [Abstract] [Full Text] [Related]

  • 32. Clinical evaluation of a paclitaxel-eluting balloon for treatment of femoropopliteal arterial disease: 12-month results from a multicenter Italian registry.
    Micari A, Cioppa A, Vadalà G, Castriota F, Liso A, Marchese A, Grattoni C, Pantaleo P, Cremonesi A, Rubino P, Biamino G.
    JACC Cardiovasc Interv; 2012 Mar 28; 5(3):331-8. PubMed ID: 22440500
    [Abstract] [Full Text] [Related]

  • 33. Cost-effectiveness analysis of paclitaxel-coated balloons for endovascular therapy of femoropopliteal arterial obstructions.
    Diehm N, Schneider H.
    J Endovasc Ther; 2013 Dec 28; 20(6):819-25. PubMed ID: 24325699
    [Abstract] [Full Text] [Related]

  • 34. Commentary: intravascular ultrasound for femoropopliteal stenting: can it predict outcomes with current-generation stents?
    Foley TR, Armstrong EJ.
    J Endovasc Ther; 2015 Jun 28; 22(3):350-1. PubMed ID: 25904483
    [No Abstract] [Full Text] [Related]

  • 35. Biologic Drug Effect and Particulate Embolization of Drug-Eluting Stents versus Drug-Coated Balloons in Healthy Swine Femoropopliteal Arteries.
    Torii S, Yahagi K, Mori H, Harari E, Romero ME, Kolodgie FD, Young B, Ragheb A, Virmani R, Finn AV.
    J Vasc Interv Radiol; 2018 Jul 28; 29(7):1041-1049.e3. PubMed ID: 29754850
    [Abstract] [Full Text] [Related]

  • 36. Drug-eluting balloons for femoropopliteal lesions show better performance in de novo stenosis or occlusion than in restenosis.
    Herten M, Torsello GB, Schönefeld E, Imm B, Osada N, Stahlhoff S.
    J Vasc Surg; 2015 Feb 28; 61(2):394-9. PubMed ID: 25307133
    [Abstract] [Full Text] [Related]

  • 37. Innovative technologies for SFA occlusions: drug coated balloons in SFA lesions.
    Minar E, Schillinger M.
    J Cardiovasc Surg (Torino); 2012 Aug 28; 53(4):481-6. PubMed ID: 22854528
    [Abstract] [Full Text] [Related]

  • 38. Comparison of Drug-Eluting Balloon and Standard Balloon Angioplasty for Infrapopliteal Arterial Diseases in Diabetic Patients.
    Oz II, Serifoglu I, Bilici M, Altinbas NK, Oz EB, Akduman EI.
    Vasc Endovascular Surg; 2016 Nov 28; 50(8):534-540. PubMed ID: 28081691
    [Abstract] [Full Text] [Related]

  • 39. Prime time for infrapopliteal drug-eluting stents?
    Katsanos K, Diamantopoulos A, Siablis D.
    J Endovasc Ther; 2012 Feb 28; 19(1):20-2. PubMed ID: 22313196
    [No Abstract] [Full Text] [Related]

  • 40. Drug-eluting balloons for the treatment of the superficial femoral artery in-stent restenosis: 2-year follow-up.
    Virga V, Stabile E, Biamino G, Salemme L, Cioppa A, Giugliano G, Tesorio T, Cota L, Popusoi G, Pucciarelli A, Esposito G, Trimarco B, Rubino P.
    JACC Cardiovasc Interv; 2014 Apr 28; 7(4):411-5. PubMed ID: 24630884
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.